Publications by authors named "Ina Dittrich"

Claim this Profile
N
NSCLC with uncommon EGFR mutations treated with atezolizumab plus bevacizumab and chemotherapy.
Arne Trummer, Andre Bethge, Nicolas Dickgreber, Ina Dittrich, Heiko Golpon

Lung Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nintedanib plus docetaxel after progression on first-line immunochemotherapy in patients with lung adenocarcinoma: Cohort C of the non-interventional study, VARGADO.
Christian Grohé, Thomas Wehler, Tobias Dechow, Sven Henschke, Wolfgang Schuette, Ina Dittrich

Transl Lung Cancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter randomized trial for stage IIIB/IV non-small-cell lung cancer using every-3-week versus weekly paclitaxel/carboplatin.
Wolfgang Schuette, Thomas Blankenburg, Wolf Guschall, Ina Dittrich, Michael Schroeder

Clin Lung Cancer· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III study of second-line chemotherapy for advanced non-small-cell lung cancer with weekly compared with 3-weekly docetaxel.
Wolfgang Schuette, Sylke Nagel, Thomas Blankenburg, Christine Lautenschlaeger, Klaus Hans, Ina Dittrich

J Clin Oncol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis